SHI, Shuiping,ZHANG, Qingyong,ZHAO, Ronghua,CHEN, Huihong,ZENG, Lun,OU, Daxin,LIU, Yan
申请号：
EP16877704
公开号：
EP3395371A4
申请日:
2016.12.20
申请国别(地区):
EP
年份:
2019
代理人:
摘要：
A pharmaceutical composition comprises an active component KX2-361 represented by formula 1 or a medicinal salt thereof and hydroxylpropoxyl-²-cyclodextrin. An inclusion compound is formed by KX2-361 or the medicinal salt thereof and hydroxylpropoxyl-²-cyclodextrin, and the solubility of the poorly-soluble drug KX2-361 is improved. The pharmaceutical composition can be prepared into an intravenous preparation and an oral preparation.
